针对弱势群体非ST段升高急性冠状动脉综合征的个性化管理和决策
Pablo Díez-Villanueva1,2, César Jiménez-Méndez3, Pedro Cepas-Guillén4
1Cardiology Department, Hospital Universitario La Princesa, Universidad Autónoma de Madrid, IIS-IP, Madrid, Spain.
Expert review of cardiovascular therapy
|November 3, 2025
概括
管理非ST升高急性冠状动脉综合征 (NSTE-ACS) 的老年患者需要个性化护理. 量身定制的抗血栓治疗,仔细考虑侵入性策略和综合心脏康复 (CR) 改善了患有并发症的脆弱个体的结果.
科学领域:
- 心脏病学 心脏病学
- 老年病的医生 老年病的医生
- 内部医学 内部医学
背景情况:
- 急性冠状动脉综合征 (ACS) 是导致死亡的主要原因,特别是在老年人中.
- 在患有贫血或慢性病 (CKD) 等并发症的脆弱老年患者中管理ACS缺乏量身定制的指导方针.
- 非ST海拔ACS (NSTE-ACS) 在这个弱势群体中提出了独特的挑战.
研究的目的:
- 审查老年患者NSTE-ACS的管理.
- 专注于抗血栓治疗,侵入性策略和心脏康复 (CR).
- 为解决患有虚弱,心房动 (AF) 和CKD的患者的具体考虑.
主要方法:
- 对重点研究NSTE-ACS的老年患者的研究的综述.
- 对抗血栓治疗,侵入性手术和CR方法的分析.
- 考虑患者的因素,如虚弱,AF和CKD.
主要成果:
- 个性化管理对于老年NSTE-ACS患者至关重要.
- 个性化抗血栓治疗 (例如,克洛皮多格勒 + 治疗AF的DOACs) 提高了安全性.
- 早期的侵入性策略可能对一些人有好处,但对于脆弱的患者存在风险.
- 综合老年评估 (CGA) 和多学科护理是必不可少的.
- 家庭式/混合式CR与护理人员集成显示出有希望的结果.
结论:
- 在老年人中最佳的NSTE-ACS管理需要个性化,多学科的方法.
- 与患者的脆弱性和并发症平衡抗血栓和侵入性策略是关键.
- 整合CGA和量身定制的CR计划可以显著改善弱势老年人的结果.
相关概念视频
01:28Acute Coronary Syndrome IV: Interprofessional Care
211
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
211
01:26Acute Coronary Syndrome V: Nursing Management
261
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
261
01:30Acute Coronary Syndrome I: Introduction
772
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
772
01:20Angina V: Nursing Management
283
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
283
01:26Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
01:26Angina IV: Management
230
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
230